Clinical Trial With Aconite Pain Oil in Oncology Patients Under Chemotherapy to Prevent CIPN Grade-II, to Reduce Symptoms and to Improve the Quality of Life of Patients With CIPN

PHASE3RecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

March 13, 2024

Primary Completion Date

August 1, 2027

Study Completion Date

August 1, 2027

Conditions
Chemotherapy-induced Polyneuropathy
Interventions
DRUG

Aconite pain oil

Participants apply 6 ml oil topically 2 times per day (morning and evening) for 15 to 27 weeks on chemotherapy-free days as long as they receive chemotherapy.

DRUG

Placebo

Participants apply 6 ml oil topically 2 times per day (morning and evening) for 15 to 27 weeks on chemotherapy-free days as long as they receive chemotherapy.

Trial Locations (1)

68167

RECRUITING

Medizinische Fakultät Mannheim der Uniklinik Heidelberg, Mannheim

All Listed Sponsors
lead

WALA Heilmittel GmbH

OTHER